The aim of this study was to describe plasma ceramides profile in adolescents with and without hepatic steatosis and evaluate the association between specific ceramides and ALT/AST ratio, independently of obesity as well as assess if any of the analyzed ceramides could be an adequate biomarker to predict hepatic steatosis. The gene discussed is GPT; the disease is Hepatic steatosis.